CUAMC
CGEM icon

China Universal Asset Management Company’s Cullinan Oncology CGEM Stock Holding History

China Universal Asset Management Company’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Sell
9,781
-703
-7% -$10.4K 0.01% 362
2026
Q1 		$149K Buy
10,484
+858
+9% +$11K 0.01% 376
2025
Q4 		$99.6K Sell
9,626
-729
-7% -$6.58K 0.01% 412
2025
Q3 		$61.4K Sell
10,355
-1,498
-13% -$11K 0.01% 418
2025
Q2 		$89.3K Buy
11,853
+116
+1% +$932 0.01% 375
2025
Q1 		$88.8K Sell
11,737
-609
-5% -$5.84K 0.01% 365
2024
Q4 		$150K Buy
12,346
+1,195
+11% +$17.2K 0.01% 350
2024
Q3 		$187K Buy
11,151
+4,380
+65% +$77.7K 0.02% 309
2024
Q2 		$118K Sell
6,771
-2,225
-25% -$47.4K 0.02% 292
2024
Q1 		$153K Buy
8,996
+4,042
+82% +$62.5K 0.02% 324
2023
Q4 		$50.5K Buy
4,954
+3,859
+352% +$34.2K 0.01% 370
2023
Q3 		$9.91K Buy
1,095
+579
+112% +$6.03K ﹤0.01% 346
2023
Q2 		$5.55K Sell
516
-17
-3% -$181 ﹤0.01% 360
2023
Q1 		$5.45K Buy
533
+68
+15% +$750 ﹤0.01% 358
2022
Q4 		$4.91K Buy
465
+38
+9% +$462 ﹤0.01% 299
2022
Q3 		$5K Buy
+427
New +$5.75K ﹤0.01% 268

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

China Universal Asset Management Company's CGEM Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Cullinan Oncology (CGEM) stake by 6.7% in Q2 2026, selling an estimated $10.4K and leaving 9,781 shares worth $178K. The position accounts for 0.01% of the portfolio, ranked #362.

China Universal Asset Management Company first reported a position in CGEM in Q3 2022 and has held it in 16 quarters since. The position peaked at $187K in Q3 2024. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • China Universal Asset Management Company held 9,781 shares of Cullinan Oncology worth $178K as of Q2 2026.
  • China Universal Asset Management Company sold 703 Cullinan Oncology shares in Q2 2026, an estimated $10.4K.
  • Cullinan Oncology made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #362 holding.
  • China Universal Asset Management Company first reported a position in Cullinan Oncology in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Cullinan Oncology position peaked at $187K in Q3 2024.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.